DTL
APLS

Dynamic Technology Lab’s Apellis Pharmaceuticals APLS Stock Holding History

Dynamic Technology Lab’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,937
Closed -$318K – 981
2024
Q4 		$318K Buy
+9,937
New +$299K 0.05% 616
2022
Q3 		– Sell
-5,370
Closed -$243K – 1105
2022
Q2 		$243K Buy
+5,370
New +$245K 0.03% 846
2018
Q4 		– Sell
-25,164
Closed -$447K – 960
2018
Q3 		$447K Buy
+25,164
New +$465K 0.06% 579

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dynamic Technology Lab's APLS Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Apellis Pharmaceuticals (APLS) in Q1 2025, closing a stake of 9,937 shares — an estimated $318K sold.

Dynamic Technology Lab first reported a position in APLS in Q3 2018 and held it in 3 quarters. The position peaked at $447K in Q3 2018. 255 funds tracked by Wall St. Rank hold APLS as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Apellis Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 9,937 Apellis Pharmaceuticals shares in Q1 2025, an estimated $318K.
  • Dynamic Technology Lab first reported a position in Apellis Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Dynamic Technology Lab's Apellis Pharmaceuticals position peaked at $447K in Q3 2018.
  • 255 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.